32 results
8-K
EX-10.10
COCP
Cocrystal Pharma Inc
7 Jul 11
Acquires Biozone Laboratories, Inc. and Related Companies
12:00am
.
(a) Termination Due To Executive's Death or Disability. In the event Executive's employment with BioZone is terminated due to his death or disability … and unpaid Base Salary through the date of death or date of termination of Executive's employment by BioZone ("Termination Date") for disability, payable
8-K
EX-10.8
COCP
Cocrystal Pharma Inc
7 Jul 11
Acquires Biozone Laboratories, Inc. and Related Companies
12:00am
To Executive's Death or Disability. In the event Executive's employment with BioZone is terminated due to his death or disability, Executive, his estate or his … through the date of death or date of termination of Executive's employment by BioZone ("Termination Date") for disability, payable in a cash lump sum
8-K
EX-10.9
COCP
Cocrystal Pharma Inc
7 Jul 11
Acquires Biozone Laboratories, Inc. and Related Companies
12:00am
with BioZone's applicable policies.
10. TERMINATION OF EMPLOYMENT.
(a) Termination Due To Executive's Death or Disability. In the event Executive's … employment with BioZone is terminated due to his death or disability, Executive, his estate or his beneficiaries, as the case may be, shall
S-8
EX-10.1
COCP
Cocrystal Pharma Inc
11 May 18
Registration of securities for employees
4:16pm
, as it may be amended from time to time.
1.30. “Retirement” shall mean the termination of the employment, other than for Cause or due to death … .Termination of Employment Due to Death. Subject to the terms of the Plan, any written agreement between the Participant and the Company
8-K
EX-10.2
COCP
Cocrystal Pharma Inc
8 Jan 14
Completion of Acquisition or Disposition of Assets
12:00am
twelve-month period or for 90 consecutive days as a result of incapacity due to mental or physical illness.
(b) DEATH. Automatically on the date of death … by the Company to the Executive no earlier than two (2) years after the Effective Date of an involuntary termination without Cause and other than due to death
8-K
EX-10.1
mhs01c2iov 40kq
8 Jan 14
Completion of Acquisition or Disposition of Assets
12:00am
S-8
EX-10.1
47qbf3xofunrqymo
2 Jan 14
Registration of securities for employees
12:00am
8-K
EX-4.1
jc493hwevttb019ni
1 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.4
oc66a1x1u7
1 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.6
8i4qkrojn6aze33
1 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
0iljk1g8
19 Feb 21
Amendments to Articles of Incorporation or Bylaws
8:30am
8-K
EX-99.1
1bw47wjsr9
13 Nov 23
Cocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
8:15am